Clinical Trial

Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107

Name: Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107 — clinical trial record (NCT07292571)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation Phase 2

View on ClinicalTrials.gov →

Summary

The study should evaluate the \[99mTc\]Tc -ZHER2:4107 accumulation in primary tumour of breast cancer patients with different HER2 expression

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-15.

Trial Details

NCT Number	NCT07292571
Lead Sponsor	Tomsk National Research Medical Center of the Russian Academy of Sciences Collaborators: Uppsala University
Conditions	Primary Breast Cancer
Enrollment	50 participants
Start Date	2025-10-20
Primary Completion	2026-03-30 (estimated)
Study Completion	2026-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-24